Bodycote
BOY · Main Market · Industrial Goods and Services · mcap £1,541m · 910.0p 3 open situations →
Open · 3
FMR LLC selling down
Next: 4.1404% still held
- 10 Aug 2026 4.1404%
- 6 Jul 2026 9.0652%
- 28 May 2026 9.9668%
- 22 Apr 2026 10.0075%
Optimise programme and plant closures
Includes Sale of 10 French sites – Completed; €22m cash received from Arcole
Optimise delivered a £4m benefit in 2025, with about £4m more expected in 2026. By the H1 results of 28 July 2026, 27 of 31 planned plant closures, disposals and consolidations were complete (21 fully exited at end April), with a further c.£1m benefit in H1. Non-Core revenue fell 72% to £9.2m. The company is exploring expanding the scope; no decisions yet.
- Progress
- 27 of 31 planned closures, disposals and consolidations complete (28 July 2026) 28 Jul 2026 ↗
- H1 benefit
- further c.£1m of improvements delivered in H1 2026 28 Jul 2026 ↗
- Non-Core revenue
- £9.2m in H1 2026, down 71.6% from £32.4m 28 Jul 2026 ↗
- Scope
- Exploring expansion to structurally challenged Automotive and Industrial regional markets; no final decisions 28 Jul 2026 ↗
- Exceptional charge
- £10.4m in H1 2026, almost entirely Optimise 28 Jul 2026 ↗
Next: Decision on expanding Optimise to more sites; further closures
- 28 Jul 2026 27 of 31 closures complete; scope expansion explored
- 27 May 2026 On track; 21 of 31 sites exited
- 11 Mar 2026 Well progressed; £4m benefit in 2025, c.£4m more in 2026
- 16 Jan 2026 Portfolio reshaping continues with a bolt-on
Sale of 10 French sites
Part of Optimise programme and plant closures – 27 of 31 closures complete; scope expansion explored
- 21 Nov 2025 Completed; €22m cash received from Arcole
- 18 Nov 2025 On track, nearing completion
Closed · 3
Company filings. Not investment advice.